Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder.
about
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depressionPharmacokinetic evaluation of fluvoxamine for the treatment of anxiety disorders.Agomelatine for the treatment of generalized anxiety disorder.Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review.Pooled Analysis of Four Non-Interventional Studies: Effectiveness and Tolerability of the Antidepressant Agomelatine in Daily Practice.Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors.Is there an association between severity of illness and psychiatric symptoms in patients with chronic renal failure?
P2860
Q28651498-E1BE0699-2AA0-44AB-9C8D-E3A782A860FAQ38366480-BE3E993A-BB58-4192-8BC5-73FBA9E12F36Q38668480-4C785B57-BBDB-470C-BCF3-76E30184ACAEQ38825574-68895D4B-DCD5-4400-811E-130835845F40Q38953673-3E72B74A-4D09-4577-A8B5-886513965C96Q39284667-3020D163-109D-445A-BF4A-E1C5471C400DQ47555840-2F6ADB98-8AF9-4353-84E7-6CF558196F58
P2860
Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacokinetic evaluation of ...... generalised anxiety disorder.
@en
type
label
Pharmacokinetic evaluation of ...... generalised anxiety disorder.
@en
prefLabel
Pharmacokinetic evaluation of ...... generalised anxiety disorder.
@en
P2860
P1476
Pharmacokinetic evaluation of ...... generalised anxiety disorder.
@en
P2093
Alfredo Carlo Altamura
Massimo Carlo Mauri
P2860
P304
P356
10.1517/17425255.2014.907794
P407
P577
2014-04-09T00:00:00Z